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Summary 
In mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS), structural 
abnormalities are present not only in the hippocampus, but also in the white matter with 
ipsilateral predominance. Although the timing of epilepsy onset is commonly associated with 
clinical and semiological dissimilarities, limited data exist regarding white matter diffusion 
changes with respect to age at epilepsy onset. The aim of this study was to investigate 
diffusion changes in the white matter of unilateral MTLE-HS patients with respect to clinical 
parameters and to compare them to an age- and sex matched healthy control group. Apparent 
diffusion coefficients (ADCs) were derived using mono-exponential approaches from 22 (11 
early and 11 late age at onset) unilateral MTLE-HS patients and 22 age- and sex matched 
control subjects after acquiring diffusion-weighted images on a 3T MRI system. Data were 
analyzed using two-tailed t-tests and multiple linear regression models. In the early onset 
MTLE-HS group ADC was significantly elevated in the ipsilateral hemispheric (p=0.04) and 
temporal lobe white matter (p=0.01) compared to controls. These differences were not 
detectable in late onset MTLE-HS patients. ADC of the early onset MTLE-HS group was 
negatively related to age at epilepsy onset in the ipsilateral hemispheric white matter (p=0.03) 
and the uncinate fasciculus (p=0.03), while in late onset patients ADC was no longer 
dependent on age at epilepsy onset itself, but rather on the seizure frequency in the ipsilateral 
uncinate fasciculus (p=0.03). Such diffusivity pattern has been associated with chronic white 
matter degeneration, reflecting myelin loss and higher extracellular volume which are more 
pronounced in the fronto-temporal regions and also depends on clinical features. In the early 
onset group, the timing of epilepsy seems to be the major cause of white matter abnormalities 
while in late onset disease it has a secondary role in provoking diffusion changes. 
Keywords: Mesial temporal lobe epilepsy with hippocampal sclerosis, age at epilepsy onset, 
diffusion-weighted imaging, apparent diffusion coefficient 
1. Introduction 
Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) is the most common 
focal epilepsy syndrome in adults [1-3]. It is well known that structural abnormalities 
associated with MTLE-HS involve not only the hippocampus and the structures of the limbic 
system [4-7], but also the bilateral white matter (WM) with ipsilateral predominance [8-17]. It 
might be hypothesized that neuronal dysfunction/loss in the sclerotic hippocampus causes 
damage to WM structures connected to the epileptic foci due to the excitotoxic effects of the 
spreading epileptogenic activity which then induces microstructural abnormalities far away 
from the seizure focus [8, 18]. Over the last years, diffusion-weighted imaging (DWI) was 
established as a useful tool to measure microstructural changes of the brain tissue in a variety 
of neurological diseases [19, 20], including epilepsy [21]. Most of these studies focus on 
specific individual WM tracts and make inferences about microstructural integrity of axons 
and myelin sheaths through the analysis of diffusivity perpendicular and parallel to the tracts. 
In our previous study we found that the age at epilepsy onset (AAO) may distinguish different 
clinical subgroups in MTLE-HS [22]. The AAO is commonly associated with clinical and 
semiological dissimilarities [22, 23]. Although the age at first non-provoked seizure can have 
a decisive effect on brain tissues in MTLE-HS, limited data exist regarding WM diffusion 
changes with respect to the epilepsy-related clinical parameters such as AAO and chronic 
seizure activity. To shed light on these issues, we investigated diffusion changes in the WM of 
MTLE-HS patients with respect to clinical parameters and compared them to an age- and sex 
matched healthy control group. We hypothesized that chronic WM damage occurs in both the 
early and the late onset disease groups, but the extent of WM damage is different according to 
the timing of epilepsy onset. 
2. Materials and methods 
The experimental protocol was approved by the local Ethical Committee and performed in 
accordance with the ethical standards described in the Declaration of Helsinki (1964). 
Participants were informed about the procedure and they signed an informed consent prior to 
the examination. 
2.1. Subjects 
Inclusion criteria for patients: 
(1) Detailed presurgical evaluation or under the care of outpatient clinic 
(2) Head magnetic resonance imaging (MRI) with epilepsy specific protocol 
(3) Unilateral hippocampal sclerosis 
Twenty-two patients (14 female) with temporal lobe epilepsy accompanied by unilateral 
hippocampal sclerosis were collected in the study (14 right-sided, 8 left-sided). All patients in 
the study presented initially to the tertiary epilepsy center and underwent a 32- to 64 -channel 
surface non-invasive electroencephalogram (EEG) monitoring. The electrodes were placed 
according to 10–10 system; the number of electrodes and their placement varied individually 
corresponding to the suspected epileptogenic region and side. FP1, F3, C3, P3, O1, F7, FT7, 
T7, TP7, P7, FT9, TP9, homologous right-sided electrodes, PZ, CZ, FZ were always used. 
Thirteen patients underwent an adult presurgical evaluation protocol including continuous 
video-EEG monitoring, neuropsychological testing and high resolution head MRI with 
epilepsy specific protocol. The remaining nine patients were examined with long term EEG 
and they also had high resolution head MRI with epilepsy specific protocol. Clinical MR 
images were analyzed by a trained neuroradiologist (P. Ba.) with 23 years of experience in 
epilepsy imaging. Neither high resolution head MRI with epilepsy specific protocol, nor 
presurgical evaluation using continuous video-EEG monitoring showed the existence of 
bitemporal epilepsy. Patients with neurodegenerative disorders, intracranial tumors, cognitive 
deficits and those who underwent previous brain surgery were excluded from the study. The 
following clinical data were collected for each MTLE-HS patient before the MRI 
examination: age, sex, seizure frequency, AAO, disease duration, level of education, history 
of febrile seizure, occurrence of generalized tonic-clonic seizure within the last 5 years, 
current and previous antiepileptic drugs, head trauma prior to AAO, history of brain infections 
such as encephalitis/meningitis and possible perinatal complication. Seizure frequency was 
determined from the seizure diary completed by the patient and defined as the mean 
frequency of complex partial seizures per month during at least the last 12 months prior to 
enrollment. In order to examine the effect of AAO on WM diffusion, patients were divided 
into two groups according to the median AAO: one group of early onset patients (N=11; 9F) 
with AAO≤16 years and the other group of late onset subjects (N=11; 5 F) with AAO>16 
years. All patients were taking antiepileptic medication at the time of study. 6 patients (1 early 
onset MTLE-HS patient) were treated with a single drug (carbamazepine [CBZ], 
levetiracetam [LEV], oxcarbazepine [OXCBZ] or valproate [VPA], whereas sixteen patients 
(10 early onset MTLE-HS patient) received more than one drug. Lamotrigine (LTG) and 
clobazam were used most frequently as adjunct drugs in these cases. CBZ/OXCBZ or sodium 
channel blockers (LTG, CBZ, OXCBZ and Lacosamide) as a group or drug polytherapy 
showed no significant effect on diffusion in the ipsilateral hemispheric, temporal lobe WM or 
in the uncinate fasciculus. Therefore these variables were not considered as confounding 
factors in the final statistical models. Clinical and demographic details for MTLE-HS patients 
are summarized in Table 1. 
22 healthy control subjects (14 female; age range 19-66 years; mean age 43.5±14.4 years) 
were also examined and matched for age and sex to the early (N=11, 9 female age range 19-
56 years; mean age 39.4±13.9 years) and the late (N=11, 5 female age range 21-66 years; 
mean age 47.6±14.2 years) onset patient groups. Control volunteers were not included if they 
had alcohol or drug abuse, psychiatric illness, traumatic brain injury or history of significant 
medical or neurological conditions that would be associated with remarkable changes in the 
brain such as seizures, stroke or migraine headache [24]. 
2.2. Magnetic Resonance Imaging 
All the measurements were carried out using a 3T Magnetom TIM Trio whole-body MRI 
scanner (Siemens AG, Erlangen, Germany). 
In all patients at least two MRI were performed:  
a) an MRI with epilepsy specific protocol which is part of our standard clinical practice and of 
inclusion criteria for study purpose to screen HS. Beyond the routine axial, coronal T2-
weighted measurements, the epilepsy specific protocol also contained the 2D FLAIR imaging 
sequence with fat suppression and T1-weighted high-resolution images (voxel size: 
0.98x0.98x0.98) to detect subtle structural alterations in the mesial temporal lobe. Routine 
DWI was carried out to localize the epileptogenic foci. 
b) An MRI with research protocol was also obtained for all patients between January 2013 
and June 2015 at least 48 hours after the last ictus. For tissue segmentation and registration a 
T1-weighted 3D magnetization-prepared rapid acquisition with gradient echo (MPRAGE) 
sequence was utilized using the following parameters: TR/TE/TI = 2530/3.4/1100 ms; flip 
angle = 7 degrees; 176 sagittal slices; slice thickness = 1 mm; field of view = 256x256 mm
2
; 
matrix size = 256 x 256; bandwidth = 200 Hz/pixel. To investigate diffusion signal changes, a 
diffusion-weighted 2D spin-echo echo-planar imaging sequence using a 3-scan trace mode 
was performed (TR/TE = 4800/128 ms; slice thickness = 3.5 mm; interslice gap= 1 mm; field 
of view = 188x250 mm
2
; matrix size = 144x192; bandwidth = 1302 Hz/pixel; number of 
averages = 5; b-values = 0, 500, 1000 s/mm
2
). Diffusion weighting was applied in the (1.0 1.0 
-0.5), (1.0 -0.5 1.0) and (-0.5 1.0 1.0) directions. Trace image was formed for each b-value 
(except b = 0 s/mm
2
) by calculating the geometric mean (Ixyz) of the signals in the three 
orthogonal spatial directions (Ix, Iy and Iz) (E.q.1): 
              
        
                              
         E.q.1 
where I0 is the signal intensity without diffusion weighting, b is the b-value, ADCxx, ADCyy, 
ADCzz are the apparent diffusion coefficients measured along the three diffusion-sensitizing 
directions and the ADC is the average of them (E.q.2): 
    
                 
 
         E.q.2 
2.3. Image processing 
2.3.1. Preprocessing 
Diffusion data were first corrected for eddy current distortion and simple head motion using a 
12 degrees of freedom affine registration to the volume without diffusion-weighting [25]. The 
Brain Extraction Tool, provided by FMRIB Software Library, was applied on both MPRAGE 
and DWI data to eliminate non-brain tissues [26]. 
2.3.2. Regions of interest analysis 
Subcortical hemispheric WM was segmented by FMRIB's Automated Segmentation Tool to 
evaluate global white matter deviations [27]. In order to examine regional subcortical WM 
abnormalities, frontal, temporal, parietal and occipital WM lobes were segmented using 
Freesurfer 5.3 image analysis suite (https://surfer.nmr.mgh.harvard.edu/) [28]. Error 
correction was performed when necessary, based on the recommended reconstruction 
workflow (https://surfer.nmr.mgh.harvard.edu/fswiki/RecommendedReconstruction). To 
evaluate diffusion changes in specific WM bundles, three regions of the limbic tracts (left and 
right Hippocampal Cingulum, Fornix cres with Stria terminalis, Uncinate fasciculus) and one 
region of association tract (left and right Sagittal Stratum including inferior longitudinal 
fasciculus and inferior fronto-occipital fasciculus) were created as Regions of Interest (ROIs) 
using ICBM-DTI-WM atlas with reference to the MRI Atlas of Human White Matter 2
nd
 
edition [29]. These regions were chosen because they present the location where functional 
abnormalities have been consistently observed in patients with MTLE-HS [30, 31]. Image 
registrations were performed using FMRIB's Linear- and Non-Linear Image Registration 
Tools (FLIRT and FNIRT) [32, 33]. For tract based analysis, MPRAGE images were spatially 
registered into MNI152 T1-weighted 1mm standard space image using a two-step process: 
1) Brain-extracted MPRAGE was linearly registered to standard space with 12 degrees-of-
freedom, 
2) after registration was refined by FNIRT, an inverse transformation was applied to warp the 
ICBM-DTI-WM atlas labels into the MPRAGE space. 
In order to derive WM labels, the brain-extracted b0 image of each subject was linearly 
registered to that subject’s brain-extracted MPRAGE image using a 6 degrees-of-freedom 
linear fit. Finally, the inverse of the spatial transformation from diffusion space to MPRAGE 
space was applied to align the segmented brain masks to diffusion space, where diffusion 
analyses were performed. 
The resulting masks were eroded by using a 2D kernel of 3x3x1 voxels to avoid partial 
volume effects and to minimize possible impacts of misregistration. ROIs were defined as the 
eroded WM masks and obtained separately for both left and right sides of the structures 
(Figure 1). 
2.4. Diffusion analysis 
Diffusion data processing was carried out using Matlab
®
 software’s curve fitting toolbox and 
a self-written program code (The MathWorks, Inc., Natick, MA). ADC was measured within 
each ROI by calculating and mono-exponentially fitting the mean signal intensity for the b0, 
b500 and b1000 images using the equation of E.q.1. 
2.5. Statistical evaluation 
Data analyses were performed using SPSS
®
 statistical software version 20.0 (IBM Corp., 
Armonk, NY). Differences were estimated by independent two-tailed t-tests for Gaussian 
values. Before using parametric t-tests, the homogeneity of variance was inspected by 
Levene’s test, while the normality of data was examined by Shapiro-Wilk statistics for 
independent samples. Welch’s correction was applied for parametric data demonstrating 
unequal variances. Multiple linear regression models were constructed to determine whether 
ADC was related to predictors, such as AAO, seizure frequency, age, sex in patients while age 
and sex in the control group. The assumptions of multiple linear regressions were satisfied, as 
judged by testing for linearity, normality assumptions of the residues, outliers, independence 
of errors, homoscedasticity and multi-collinearity [34]. Results were considered significant at 
p≤0.05 for all statistical tests. 
3. Results 
ADC values measured in patients were presented as the side ipsilateral and contralateral to the 
seizure focus and compared to the corresponding side of healthy controls. 
3.1. Differences between groups 
Except for the ipsilateral hemispheric, temporal lobe WM and the uncinate fasciculus, none of 
the other regions showed ADC difference between patients and controls. There was a 
significant ADC difference of the ipsilateral hemispheric WM between the whole patient and 
control groups (Figure 2a). Here, patients in the early onset MTLE-HS group showed higher 
ADC compared to their matched controls, but it disappeared in the late onset group (Table 2). 
In the ipsilateral temporal lobe WM, ADC was only tendentiously higher (p=0.056) in the 
whole patient group compared to controls (Figure 2b). Conversely, ADC was significantly 
elevated (p=0.01) in patients with early onset MTLE-HS (8.21±0.30) compared to controls 
(7.88±0.29), but this association was missing in late onset patients (Table 2). 
In the ipsilateral uncinate fasciculus, a significant ADC difference was observed (p=0.02) 
between the whole patient (7.93±0.50) and control groups (7.61±0.36), however neither the 
early nor the late onset patient groups showed significant ADC elevation compared to controls 
(Table 2). 
3.2. Differences within groups 
Patients with early onset disease had higher ADC (p=0.04) in the ipsilateral side of temporal 
lobe WM (8.21±0.30) compared to the contralateral side (7.97±0.20) but this difference was 
not present in the late onset group. Besides the temporal lobe WM, data derived from patients 
were not significantly different between the ipsi- and the contralateral sides. 
Multiple linear regression analysis indicated significant effects of AAO, age and seizure 
frequency on ADC, while no sex differences were observed in patients. There were no 
significant effects of either age or sex on ADC in controls. 
In the whole patient group, ADC showed negative relationship with AAO in the ipsilateral 
side of the hemispheric, temporal lobe WM and the uncinate fasciculus while ADC was 
positively related to age in the ipsilateral hemispheric WM and the uncinate fasciculus 
(corrected p and r values in Table 3.). 
In early onset patients, ADC was negatively related to AAO in the ipsilateral hemispheric 
WM (Table 3.) and the uncinate fasciculus (Table 3, Figure 3a). In the ipsilateral temporal 
lobe WM, ADC tended to decrease as a function of AAO, but no significant correlation was 
found between them (Table 3). 
In late onset patients, AAO had no contribution to ADC, but seizure frequency revealed a 
significantly positive influence on diffusion in the ipsilateral uncinate fasciculus (Table 3, 
Figure 3b). 
4. Discussion 
The aim of this study was to evaluate diffusion changes in hemispheric, lobar WM and 
selected bundles in patients with MTLE-HS and to examine their relation to clinical 
parameters. Three major findings emerged: 
(1) The ipsilateral hemispheric WM and the uncinate fasciculus showed ADC differences 
between patients and controls. 
(2) In the early onset MTLE-HS group, ADC was significantly elevated not only in the 
ipsilateral hemispheric WM but also in the ipsilateral temporal lobe compared to matched 
controls. These differences were not detectable in the late onset MTLE-HS group. 
(3) AAO was of statistical significance as demonstrated by the negative relationship with 
ADC in the ipsilateral hemispheric, temporal lobe WM and the uncinate fasciculus. In the 
early onset group, ADC was negatively related to AAO in the ipsilateral hemispheric WM and 
the uncinate fasciculus. In the late onset group, seizure frequency had positive influence on 
ADC in the ipsilateral uncinate fasciculus. 
A number of structural and DWI studies examined the presence and the extent of WM 
abnormalities in temporal lobe epilepsy. Quantitative MR volumetric data showed that 
temporal lobe epilepsy with unilateral hippocampal sclerosis is associated with significant 
reduction in the cerebral WM volume in temporal and extratemporal regions [8]. The 
causality between the clinical markers (e. g. recurrent seizure-related factors, underlying 
pathology) and the temporal/extratemporal WM volumetric abnormalities was found to be 
controversial [9]. Seidenberg et al. found a greater reduction in the ipsilateral WM volume 
relative to the contralateral side [8]. This volume asymmetry was associated with both the 
duration of epilepsy and the AAO. According to others, WM differences in temporal lobe 
epilepsy patients were detectable compared to healthy controls but they were more 
pronounced in the early onset group [16, 23]. Additionally, the earlier AAO rather than the 
duration of the disease was associated with reduced cerebral WM volume, and it was not 
related to initial precipitating injury, occurrence/number of generalized seizures and number 
of antiepileptic drugs [9]. Beyond the volumetric studies there have been numerous reports 
based on diffusion imaging in adult temporal lobe epilepsy patients in which bilateral WM 
alterations can usually be detected in the limbic and non-limbic areas with ipsilateral 
predominance [10-16]. These changes are more extensive in patients with mesiotemporal 
sclerosis than in the non-lesional group [11, 18]. Although the underlying cause is not clear 
for such alterations, several possible theories exist. According to one hypothesis, these 
changes may be the result of neuronal loss in epileptic foci causing secondary axonal 
degeneration far away from the seizure focus. There are important fronto-temporal tracts or 
other pathways connecting the two temporal lobes or hemispheres (e. g. uncinate fasciculi, 
arcuate fasciculi, corpus callosum) which are commonly associated with diffusion alterations. 
These are frequently involved in seizure propagation from the temporal lobe and might 
explain the role of recurring epileptic activity with abnormal neuronal firing on WM 
abnormalities. Findings of WM diffusion alterations have also been complemented by gray 
matter disruption. These studies have demonstrated bilateral extensive cortical gray matter 
volume loss in MTLE-HS [35] which is greater in patients with left sided disease [36]. The 
extant of gray matter disruption is closely related to the start of the disease [37] and also more 
severe in regions that are anatomically and functionally connected to the hippocampus [38, 
39]. An extensive literature has shown disruptions in inter-regional fiber diffusivity in the 
mesiotemporal and the fronto-temporal networks [30, 40] and in the speech dominant 
hemisphere [41] suggesting decreased fiber arrangement and altered myelin membranes. 
These findings support the hypothesis that gray matter volume loss and WM damage may be 
related to each other and probably due to the excitotoxic effects of spreading epileptogenic 
activity in brain regions that are directly or indirectly connected to the hippocampus. 
Our results revealed that ADC derived from the ipsilateral hemispheric WM of MTLE-HS 
patients was higher compared to the corresponding side of controls. These are consistent with 
previous findings suggesting that WM abnormalities are most pronounced in the cerebral 
hemisphere ipsilateral to the seizure focus [16, 30, 42]. Additionally, ADC of early onset 
MTLE-HS patients was elevated not only in the ipsilateral hemispheric but also in the 
ipsilateral temporal lobe WM compared to controls, however this differences were not 
detectable in late onset MTLE-HS group. According to animal and human studies, the 
impairment of WM is related to age at recurrent seizure onset and being more severe when 
seizures appeared at younger ages [9, 43]. This could be explained either by a primary 
pathology or by different neurodevelopmental processes precipitating epilepsy. However, it 
cannot be ruled out, that the adverse effect of the recurrent seizures in the developing, 
immature brain might lead to WM impairment in early onset epilepsy. Indeed, myelination 
and the consequent cerebral volume increase is a long lasting event, and occurs in the 
hippocampus and in the cerebral white matter beyond the age of 16 (the age limit of the early 
onset group in our study) [44]. 
In addition, we found that, ADC of early onset group was negatively related to AAO in the 
ipsilateral hemispheric WM and the uncinate fasciculus. But in the late onset group the 
seizure frequency had a positive influence on ADC in the ipsilateral uncinate fasciculus. It 
could be assumed that different pathophysiological mechanisms (such as seizure-related 
injury as well as epileptogenesis) and etiological factors do not equally participate in WM 
degeneration. In agreement with others, our results revealed that the uncinate fasciculus was 
impaired, particularly ipsilateral to the epileptogenic focus [15]. This impairment was related 
to the timing of epilepsy in the early onset MTLE-HS group while in late onset disease it was 
probably coming from chronic seizure activity. 
The current study has some limitations. (1) We should emphasize that one of the limitations is 
the low number of patients and controls involved. ADC in the ipsilateral temporal lobe of 
early onset patients tended to decrease as a function of AAO but no significant correlation 
was found between them. Probably the effect of AAO averaged out leaving no difference in 
diffusion due to the relatively small number of observations and large number of predictors. 
(2) In this study, 13 of the 22 patients underwent an adult presurgical evaluation protocol, 
therefore the possibility of subtle bilateral disease is not ruled out. (3) In order to perform 
powerful statistical analysis, patients were divided into two groups according to the median 
AAO as early and late onset MTLE-HS groups. Although, no significant differences were 
observed in clinical and demographic data (e.g. seizure frequency, level of education), the 
comparison of white matter diffusivity between the early and the late onset groups may be 
problematic due to the atypical average AAO of late onset patients. (4) Beside the timing of 
seizure onset, disease duration also plays an important role on MTLE-HS; however previous 
reports support the hypothesis that the age at initial precipitating injury might play the major 
role in the development of mesial temporal sclerosis [38]. (5) The frequency of seizures may 
change over years in MTLE-HS patients, which can also have dominant influence on white 
matter integrity. To shed light on this relationship, a longitudinal study is needed using a 
larger patient population. (6) Since subtle abnormalities may remain hidden with hemispheric 
and lobar approaches, particularly when they occur in small fractions of the brain, we 
performed diffusion analysis also in the tracts connected to the temporal lobe. In spite of this, 
diffusion tensor imaging would have been beneficial to investigate tract based WM deviation. 
5. Conclusion 
Taken together, ADC was higher in MTLE-HS, especially in the cerebral hemisphere 
ipsilateral to the seizure onset. Such diffusivity pattern has been associated with chronic WM 
degeneration, reflecting myelin and axonal loss, gliosis and higher extracellular volume which 
are more pronounced in the fronto-temporal regions and also depends on clinical features like 
AAO and chronic seizure activity. In the early onset MTLE-HS group, the timing of epilepsy 
seems to be the major origin of WM abnormalities while it should be assumed as a secondary 
effect provoking diffusion changes in the late onset MTLE-HS patients. Our results showed 
that, the combination of clinical data and novel MR methods has led to valuable insights into 
epilepsy-associated changes in the white matter and has increased our understanding of the 
pathophysiology of MTLE-HS. 
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Representations of the regions of interest analysis. Regional averages of ADC values were 
extracted from diffusion-weighted images using eroded masks of the left and right 
hemispheric WM (A); temporal, occipital lobes WM (B); frontal, parietal lobes WM (C); 
Uncinate Fasciculus (UNC); Fornix cres with Stria terminalis (FX with ST); Hippocampal 
Cingulum (HCg); Sagittal Stratum (SS) include inferior longitudinal fasciculus and inferior 
fronto-occipital fasciculus (D). 
Images are presented in radiological convention. 
Figure 2 
DWI images overlaid with color-coded ipsilateral hemispheric (upper left of A) and temporal 
lobe WM (upper right of B) ADC values in a representative MTLE-HS patient and a control 
subject. The box- and whiskers plots show the distribution of ADC values in the ipsilateral 
hemispheric (lower left of A) and temporal lobe WM (lower right of B) of MTLE-HS patients 
(N=22) and control subjects (N=22). The whiskers in the plot represent the minimum and the 
maximum ADC values, the cross depicts the mean while the band inside the box shows the 
median ADC. 
MTLE-HS: Mesial temporal lobe epilepsy with hippocampal sclerosis; ADC: Apparent 
diffusion coefficient. 
Figure 3 
Partial regression plots demonstrating the influence of AAO in early onset disease (A) and 
seizure frequency in late onset patients (B) on ADC in the ipsilateral uncinate fasciculus. The 
lines indicate the slope as fitted by linear regression and the 95% confidence intervals. Linear 
correlation coefficients (r) are also presented. 
MTLE-HS: Mesial temporal lobe epilepsy with hippocampal sclerosis; ADC: Apparent 
diffusion coefficient; AAO: Age at epilepsy onset. 
Table 1. Clinical and demographic details for MTLE-HS patients. 
Investigated data 
MTLE-HS patients 
Early onset group 
(N=11) 






 39.3±13.8 (19-61) 47.4±13.7 (20-63) 43.3±14.1 (19-63) 
seizure frequency
a, ‡ 4.7±5.4 (0-20) 3.2±5.3 (0-18) 4.0±5.2 (0-20) 
AAO (years)
a
 7.6±5.5 (1-16) 38.3±13.5 (17-57) 23.0±18.6 (1-57) 
level of education (years)
a
 12.7±3.5 (8-17) 11.8±2.9 (8-16) 12.3±3.1 (8-17) 
history of febrile seizure 5 2 7 
occurrence of GTCS 3 5 8 
head trauma prior to AAO 0 2 2 
mild encephalitis/meningitis 3 0 3 
perinatal complication 1 0 1 
MTLE-HS: Mesial temporal lobe epilepsy with hippocampal sclerosis; AAO: age at epilepsy onset; 
GTCS: generalized tonic-clonic seizure within the last 5 years. 
a
 Values given as: mean ± standard deviation (range). 
‡
 Seizure frequency was defined as the mean frequency of complex partial seizures per month during 
at least the last 12 months prior to enrollment. 
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Whole p=0.01 p=0.056 p=0.02 
Early onset p=0.04 p=0.01 ns
*
 
Late onset ns ns ns 
MTLE-HS: Mesial temporal lobe epilepsy with hippocampal sclerosis; WM: white matter; ns: not 
significant. 
*
Independent two-tailed t-test with Welch correction for unequal variances. 
 
Table2

























AAO p=0.02 (-0.54) p=0.001 (-0.70) p=0.006 (-0.61) 
Age p=0.009 (+0.58) ns p=0.03 (+0.51) 
seizure 
frequency 
ns ns ns 
















AAO p=0.03 (-0.76) ns p=0.03 (-0.76) 
Age ns ns ns 
seizure 
frequency 
ns ns ns 















AAO ns ns ns 
Age ns ns ns 
seizure 
frequency 
ns ns p=0.03 (+0.75) 
Sex ns ns ns 
†
Results are presented as corrected p values and linear correlation coefficients (r). 
MTLE-HS: Mesial temporal lobe epilepsy with hippocampal sclerosis; WM: white matter; AAO: Age 
at epilepsy onset; ns: not significant. 
Table3_revised
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